Pages
Home
Investments
Transaction Advisory
Investment Research and Business Due Diligence
Contact Us
Sunday, September 16, 2012
Eli LIlly Japan files for approval a liquid dosage form of Strattera (atomoxetine hydrochloride) for use in ADHD patients having difficulty in swallowing
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
